microsimulation models (Institute for Clinical Pharmacodynamics)
90
Structured Review
Institute for Clinical Pharmacodynamics
microsimulation models
Microsimulation Models, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monte+carlo+microsimulation+model/microsimulation+model/pm39636635-16-1-6
Average 90 stars, based on 1 article reviews
Microsimulation Models, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monte+carlo+microsimulation+model/microsimulation+model/pm39636635-16-1-6
Average 90 stars, based on 1 article reviews
microsimulation models - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Estimated Reduction in Health Care Spending Associated With Weight Loss in Adults. Article Snippet: Two Mutagenesis:Article Title: Ivacaftor not cost effective in cystic fibrosis with G551D mutation Article Snippet: Ivacaftor is not cost effective in patients with cystic fibrosis (CF) with the G551D mutation, according to findings of a US cost-utility analysis published in Value in Health.. As part of an evidence report by the US Institute for Clinical and Economic Review, a microsimulation model populated with data from the STRIVE and ENVISION trials and the 2016 CF Foundation patient registry was used to evaluate the cost effectiveness of ivacaftor plus best supportive care (BSC) versus BSC alone in a hypothetical cohort of 10 000 infants 6 months of age with the G551D gating mutation.. Cost effectiveness was assessed from a US healthcare payer perspective over a lifetime time horizon. |